首页> 美国卫生研究院文献>American Journal of Physiology - Regulatory Integrative and Comparative Physiology >Cardiovascular and Renal Integration: Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults
【2h】

Cardiovascular and Renal Integration: Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults

机译:心血管和肾脏整合:皮内注射内皮素-1可通过Rho激酶减轻内皮依赖性和非依赖性皮肤血管舒张

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently showed that intradermal administration of endothelin-1 diminished endothelium-dependent and -independent cutaneous vasodilation. We evaluated the hypothesis that Rho kinase may be a mediator of this response. We also sought to evaluate if endothelin-1 increases sweating. In 12 adults (25 ± 6 yr), we measured cutaneous vascular conductance (CVC) and sweating during 1) endothelium-dependent vasodilation induced via administration of incremental doses of methacholine (0.25, 5, 100, and 2,000 mM each for 25 min) and 2) endothelium-independent vasodilation induced via administration of 50 mM sodium nitroprusside (20–25 min). Responses were evaluated at four skin sites treated with either 1) lactated Ringer solution (Control), 2) 400 nM endothelin-1, 3) 3 mM HA-1077 (Rho kinase inhibitor), or 4) endothelin-1+HA-1077. Pharmacological agents were intradermally administered via microdialysis. Relative to the Control site, endothelin-1 attenuated endothelium-dependent vasodilation (CVC at 2,000 mM methacholine, 80 ± 10 vs. 56 ± 15%max, P < 0.01); however, this response was not detected when the Rho kinase inhibitor was simultaneously administered (CVC at 2,000 mM methacholine for Rho kinase inhibitor vs. endothelin-1 + Rho kinase inhibitor sites: 73 ± 9 vs. 72 ± 11%max, P > 0.05). Endothelium-independent vasodilation was attenuated by endothelin-1 compared with the Control site (CVC, 92 ± 13 vs. 70 ± 14%max, P < 0.01). However, in the presence of Rho kinase inhibition, endothelin-1 did not affect endothelium-independent vasodilation (CVC at Rho kinase inhibitor vs. endothelin-1+Rho kinase inhibitor sites: 81 ± 9 vs. 86 ± 10%max, P > 0.05). There was no between-site difference in sweating throughout (P > 0.05). We show that in young adults, Rho kinase is an important mediator of the endothelin-1-mediated attenuation of endothelium-dependent and -independent cutaneous vasodilation, and that endothelin-1 does not increase sweating.
机译:我们最近表明,内皮素-1的皮内给药减少了内皮依赖性和非依赖性的皮肤血管舒张。我们评估了Rho激酶可能介导这种反应的假说。我们还试图评估内皮素-1是否增加出汗。在12位成人(25±6岁)中,我们测量了1)通过增加剂量的乙酰甲胆碱(0.25、5、100和2,000 mM持续25分钟)诱导的内皮依赖性血管舒张期间的皮肤血管电导(CVC)和出汗。 2)通过给予50 mM硝普钠(20–25分钟)诱导的非内皮依赖性血管舒张。在使用1)乳酸林格液(对照),2)400 nM内皮素-1、3)3 mM HA-1077(Rho激酶抑制剂)或4)内皮素-1 + HA-1077处理的四个皮肤部位评估反应。药物通过微透析皮内给药。相对于对照部位,内皮素-1减弱了内皮依赖性血管舒张作用(CVC在2,000 mM乙酰甲胆碱,80±10 vs. 56±15%max,P <0.01);但是,当同时施用Rho激酶抑制剂时,未检测到此反应(Rho激酶抑制剂与内皮素-1 + Rho激酶抑制剂位点在2,000 mM乙酰甲胆碱的CVC:73±9 vs. 72±11%max,P> 0.05 )。与对照部位相比,内皮素-1减弱了非内皮依赖性血管舒张作用(CVC,92±13 vs. 70±14%max,P <0.01)。但是,在存在Rho激酶抑制作用的情况下,内皮素-1不会影响内皮依赖性血管舒张(Rho激酶抑制剂与内皮素-1 + Rho激酶抑制剂位点的CVC:81±9 vs. 86±10%max,P> 0.05)。整个出汗之间没有部位间差异(P> 0.05)。我们显示,在年轻的成年人中,Rho激酶是内皮素1介导的内皮依赖性和非依赖性皮肤血管舒张的减弱的重要介体,并且内皮素1不会增加出汗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号